update on therapeutics for muscle regeneration
play

Update on Therapeutics for Muscle Regeneration Kathryn R. Wagner, M.D., Ph.D. Center for Genetic Muscle Disorders The Kennedy Krieger Institute Johns Hopkins School of Medicine November 5, 2011 Natural History of Myopathies Myostatin

0 downloads 1 Views 1,18 MB Size Report
  1. Update on Therapeutics for Muscle Regeneration Kathryn R. Wagner, M.D., Ph.D. Center for Genetic Muscle Disorders The Kennedy Krieger Institute Johns Hopkins School of Medicine November 5, 2011

  2. Natural History of Myopathies Myostatin inhibition IGF-1 stimulation Androgens Selective Androgen Receptor Modulators (SARMS) disability years

  3. Myostatin is a TGF- β family member expressed predominantly in skeletal muscle mstn -/- wt McPherron AC, Nature 387: 83-90, 1997

  4. Myostatin mutants

  5. Myostatin function is conserved in humans Schuelke M et al., NEJM 350: 2682-2688, 2004

  6. Über berkinde der! 'Mighty mouse' gene helps super-strong boy Strong Boy Could Benefit Research on Muscular Dystrophy Bulked-up Boy Teaches Docs About Muscle Protein One Strong Tyke: Gene mutation in muscular boy may hold disease clues Superm an Lives Muscular German boy sheds new light on muscle development and genetics Muscle boy show s w ay for super athletes Muscle Boy Genetic mutation turns tot into superboy

  7. Muscle size and strength increased in myopathic mouse model lacking myostatin 2.5 .5 0.6 P<0.001 P<0.01 0.5 2 Weight (g) Force (N) 0.4 1.5 .5 0.3 1 0.2 0.5 .5 0.1 0 0 mdx wt tric gast Wagner KR et al., Ann Neurol 54: 832-836, 2002

  8. Improved regeneration and reduced fibrosis in the absence of myostatin myopathic myopathic/ no myostatin normal mouse Wagner KR et al., Ann Neurol 54: 832-836, 2002

  9. Loss of myostatin leads to faster regeneration control mstn-/- 60 4 d P<0.04 50 Fiber diameter * 40 * 30 7 d 20 10 0 uninjured day 1 day 7 day 15 day 30 uninjured 0 7 14 30 days Fiber diameter Wagner KR et al., PNAS 102: 2519-2524, 2005

  10. Fibrosis and Fat • A common feature of chronic myopathies • Presumptive Consequences: – Impaired diffusion of nutrients – Reduced contractility – Reduced compliance – Self perpetuating process – Reduced muscle regeneration Implications for future therapies • – Myoblast transplantation – Gene transfer

  11. Myostatin induces fibroblast proliferation in vitro Li ZB, Kollias HD and Wagner KR, J. Biol Chem, 2008

  12. Myostatin induces fibrosis in vivo Li ZB, Kollias HD and Wagner KR, J. Biol Chem, 2008

  13. Myostatin Inhibitors developed for clinical trials Myo-029 (neutralizing antibody, Wyeth) • – Safe in adults with muscular dystrophy – Although number of individuals treated was small, no efficacy found • RK35 (neutralizing antibody, Pfizer) ACE-031 (soluble receptor, Acceleron/Shire • – Potential for extraordinary efficacy with increased musculature measurable after single injection – Due to nose bleeds and new blood vessel growth, trial in Duchenne muscular dystrophy was terminated.

  14. Gartner Hype Cycle Myostatin inhibition

  15. Summary • Several different growth factors, including myostatin, influence muscle regeneration and can be exploited for treatment of myopathies • Blocking myostatin increases muscle growth and regeneration and decreases muscle fibrosis and fat. • Myostatin inhibitors are currently in clinical trials and have the potential to improve chronic myopathies.

  16. Acknowledgements Center for Genetic Muscle Disorders: Zhao Bo Li, MD, PhD * Tracy Zhang, MS Naili Liu, DVM Adam Moyers, MS Geni Bibat, MD Doris Leung, MD Funding: MDA NIH/NICHD Charley’s Fund wagnerk@kennedykrieger.org 443-923-9525

Recommend Documents


muscle muscle muscle muscle cytoskeleton cytoskeleton
Muscle Muscle Muscle Muscle

8/27/2018 Muscle Muscle Muscle Muscle Cytoskeleton Cytoskeleton

section 38 muscle anatomy section 38 muscle anatomy
Section 38: Muscle - Anatomy Section

Section 38: Muscle - Anatomy Section 38: Muscle - Anatomy 38-1 Muscle

for immediate release
FOR IMMEDIATE RELEASE NASDAQ: TRIL

FOR IMMEDIATE RELEASE NASDAQ: TRIL TSX: TRIL TRILLIUM THERAPEUTICS PROVIDES

proper es of muscle plan for today what s cool about
Proper@es of Muscle Plan for Today

2/2/16 Musculoskeletal Biomechanics BIOEN 520 | ME 599R Session 10

muscle tissue muscle tissue gen info
Muscle Tissue Muscle Tissue Gen. Info.

Muscle Tissue Muscle Tissue Gen. Info. Muscle tissue makes up nearly half the

regeneration
Regeneration Kattie Sepehri Every

Regeneration Kattie Sepehri Every species is capable of regeneration but

muscle physiology
Muscle Physiology Bio 219 Dr. Adam

Muscle Physiology Bio 219 Dr. Adam Ross Napa Valley College Muscle tissue

king s lynn riverfront delivery plan progress update
Kings Lynn Riverfront Delivery Plan

Kings Lynn Riverfront Delivery Plan Progress Update Preferred Masterplan

i orbital geometry ball and virtual socket ii muscle
I. Orbital Geometry Ball and virtual

I. Orbital Geometry Ball and virtual socket II. Muscle Mechanics A. Three

supported bus service review
Supported Bus Service Review Update

Supported Bus Service Review Update after Public Consultation Environment and

cha ra c te riza tio n o f gage a ntig e n e xpre ssio n
Cha ra c te riza tio n o f GAGE a ntig

Cha ra c te riza tio n o f GAGE a ntig e n e xpre ssio n in thirte e n c o

lynx distribution status and management in southern canada
Lynx distribution, status, and

Lynx distribution, status, and management in southern Canada Jeff Bowman

part 2 edcs the science
Part 2 EDCs The Science CHE-Alaska

Part 2 EDCs The Science CHE-Alaska Webinar Andrea C. Gore, PhD University

metabolomic profiles of childhood obesity
Metabolomic profiles of childhood

Note: for non-commercial purposes only Metabolomic profiles of childhood

impact of radiopharmaceutical development on the
Impact of radiopharmaceutical

Impact of radiopharmaceutical development on the management of cancer Mike

should there be
Should there be a third sex in sport?

Should there be a third sex in sport? Play The Game meeting Cologne, October

key pfizer sponsored data presentations at the american
Key Pfizer-Sponsored Data Presentations

Key Pfizer-Sponsored Data Presentations at the American Society of Clinical

antoxis overview chemistry led pla7orm company
Antoxis overview

Antoxis overview Chemistry-Led pla7orm company Recently

australian implementation
Australian Implementation of scalp

Australian Implementation of scalp cooling for prevention of chemotherapy

energy for today opportunities for tomorrow
Energy for Today. Opportunities for

Energy for Today. Opportunities for Tomorrow. July 2019 DIVERSIFIED,

regulatory initiatives for measuring the impact of risk
Regulatory initiatives for measuring

Regulatory initiatives for measuring the impact of risk minimisation measures

probl blem k knees ees
Probl blem K Knees ees an artisans

Probl blem K Knees ees an artisans science Jai Chitnavis MA MChir FRCS